Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 225-244 of 728


Old Songs, New Tests, and Expensive Childrenby George Estreich, Biopolitical Times guest contributorFebruary 20th, 2014The CEO of AOL justified a restructuring of the company’s 401(K) plan by citing two "distressed babies." This tone-deaf insensitivity was answered by a disapproving choir, but it sadly resembles too many descriptions of the "cost" of people with disabilities.
Love is in The Air Your Genesby Jessica CussinsBiopolitical TimesFebruary 14th, 2014Missing that je ne sais quoi with someone new this Valentine’s Day? A Canada-based startup claims to have mastered the science behind that illusive chemistry.
'There is no DNA Test to Prove You're Native American'by Linda GeddesNew ScientistFebruary 13th, 2014DNA testing is changing how Native Americans think about tribal membership. Yet anthropologist Kim Tallbear warns that genetic tests are a blunt tool, and tribal identity not just a matter of blood ties.
Why Family Caregivers Should Care for their Families' Genetic Inheritance Data[With CGS's Marcy Darnovsky]by Dr. Gordon AtherleyVoice AmericaFebruary 10th, 2014Marcy Darnovsky and Jeff Nisker discuss the benefits and risks associated with the use of families’ genetic inheritance data for research and for medical treatment.
Whole Genome Testing Used to Guide Breast Cancer Treatmentby Barbara CzubBioNewsFebruary 10th, 2014Whole genome testing has been used to guide tailored treatment against advanced breast cancer in a group of 43 patients.
The Path to Reading a Newborn’s DNA Mapby Anne EisenbergThe New York TimesFebruary 8th, 2014What if laboratories could run comprehensive DNA tests on infants at birth? Should parents be told of each variation, even if any risk is still unclear? Would they even want to know?
Myriad Settles Gene Patent Lawsuit Against Texas Firmby Tom HarveyThe Salt Lake TribuneFebruary 7th, 2014Myriad Genetics has reached a settlement with Gene by Gene Ltd. and vows to continue legal battles against other competitors trying to jump into the market.
Uzbekistan Is Using Genetic Testing to Find Future Olympiansby Ron Synovitz and Zamira EshanovaThe AtlanticFebruary 6th, 2014The idea of using genetic testing to spot future world-class athletes has been bandied about for years. Uzbekistan is now testing children as young as 10 to determine their athletic potential.
The $1,000 Genome: Game Changer or PR Stunt?by Jessica CussinsBiopolitical TimesFebruary 6th, 2014The DNA sequencing company Illumina announced a new product capable of sequencing an entire human genome for under $1,000. What are the hidden costs? What are the implications of reaching this long-awaited benchmark?
Genetics for the People?by Donna DickensonProject SyndicateFebruary 5th, 2014The rhetoric of personal ownership and control touted by 23andMe hides their flimsy data and actual business plan.
Ethics Questions Arise as Genetic Testing of Embryos Increasesby Gina KolataThe New York TimesFebruary 3rd, 2014The procedure raises unsettling ethical questions that trouble advocates for the disabled and have left some doctors struggling with what they should tell their patients.
Genetic Determinism: Why we Never Learn — And Why it Mattersby Nathaniel ComfortGenotopiaJanuary 29th, 2014Studying the history of genetics and popularization has led me to the surprising conclusion that genetic oversell is independent of genetic knowledge. We see the same sorts of articles in 2014 as we saw in 1914.
How FDA and 23andMe Dance Around Evidence That Is Not Thereby Cecile JanssensHuffington PostJanuary 27th, 2014Almost all former direct-to-consumer genetic testing companies have closed up shop. In the wake of criticism from all sides will 23andMe be next?
Right on target: New era of fast genetic engineeringby Colin BarrasNew ScientistJanuary 27th, 2014If we ever decide to genetically modify people, this is the tool to do it with.
California’s stem cell agency poised to bet big on genomics researchby David JensenSacramento BeeJanuary 26th, 2014Directors of the California stem cell agency are preparing to create one or two stem cell genomic centers that they predict will make the state a world leader in the new field.
A genetic “Minority Report”: How corporate DNA testing could put us at riskby Benjamin WinterhalterSalonJanuary 26th, 201423andMe's FDA problems are just the beginning - the company's DNA tests open up a wealth of privacy concerns.
Is genius in the genes?by Steven RoseTESJanuary 24th, 2014The debate about genes and intelligence has resurfaced, and it’s more fervent than ever. Can achievement truly be inherited? Should education be tailored to individuals’ genetic potential?
Soaring sales of 'dangerous' do-it-yourself DNA test kits: Number of websites selling products doubles in two yearsby Sean PoulterDaily Mail (UK)January 20th, 2014Sales of DNA tests for everything from the risk of developing life-threatening diseases to catching out cheating partners are booming, though many scientists suggest that DIY home DNA testing could cause real harm.
Hit-and-Miss Genetic Testingby Pete ShanksBiopolitical TimesJanuary 20th, 2014In at least four experiments, identical DNA has been sent to different direct-to-consumer testing companies. In every case, significant anomalies appeared.
Google, Tell Me. Is My Son a Genius?by Seth Stephens-DavidowitzNew York TimesJanuary 18th, 2014Google searches suggest that American parents are far more likely to want their boys smart and their girls skinny. Among those looking for information on sex selection, there is about a 10 percent preference for boys.
Displaying 225-244 of 728  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760